Literature DB >> 18042646

Biallelic inactivation of the dual oxidase maturation factor 2 (DUOXA2) gene as a novel cause of congenital hypothyroidism.

Ilaria Zamproni1, Helmut Grasberger, Francesca Cortinovis, Maria Cristina Vigone, Giuseppe Chiumello, Stefano Mora, Kazumichi Onigata, Laura Fugazzola, Samuel Refetoff, Luca Persani, Giovanna Weber.   

Abstract

CONTEXT: Dual oxidase 2 (DUOX2) is the catalytic core of the H(2)O(2) generator crucial for the iodination of thyroglobulin in thyroid hormone synthesis. DUOX2 deficiency produces congenital hypothyroidism (CH) in humans and mice. We recently cloned a novel gene, the product of which (dual oxidase maturation factor 2; DUOXA2) is required to express DUOX2 enzymatic activity.
OBJECTIVE: Our objective was to identify DUOXA2 mutations as a novel cause of CH due to dyshormonogenesis. PATIENTS: Subjects included 11 CH patients with partial iodine organification defect but negative for other known genetic causes of partial iodine organification defect.
RESULTS: One Chinese patient born to nonconsanguineous parents was homozygous for a nonsense mutation (p.Y246X), producing a truncated DUOXA2 protein lacking transmembrane helix 5 and the C-terminal cytoplasmic domain. The mutant protein was inactive in reconstituting DUOX2 in vitro. Pedigree analysis demonstrated recessive inheritance, because heterozygous carriers had normal thyroid function including negative results in neonatal TSH screening. One heterozygous carrier of Y246X was identified in unrelated Chinese controls (n = 92) but not in Caucasian or Japanese controls, indicating that homozygosity for Y246X could be a frequent cause of CH in Chinese. Functional studies suggest that the DUOXA2 paralog (DUOXA1) can partially compensate DUOXA2 deficiency, consistent with the proband having a milder CH phenotype than patients with biallelic DUOX2 nonsense mutations.
CONCLUSIONS: We report the first mutation in DUOXA2, identified in a patient with CH and dyshormonogenic goiter. Results of our studies provide evidence for the critical role of DUOXA2 in thyroid hormonogenesis. Biallelic DUOXA2 mutations are a novel genetic event in permanent CH.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18042646      PMCID: PMC2243227          DOI: 10.1210/jc.2007-2020

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  20 in total

1.  Characterization of ThOX proteins as components of the thyroid H(2)O(2)-generating system.

Authors:  Xavier De Deken; Dantong Wang; Jacques E Dumont; Françoise Miot
Journal:  Exp Cell Res       Date:  2002-02-15       Impact factor: 3.905

2.  Determination of thyroid volume by ultrasound from the neonatal period to late adolescence.

Authors:  J P Chanoine; V Toppet; R Lagasse; M Spehl; F Delange
Journal:  Eur J Pediatr       Date:  1991-04       Impact factor: 3.183

Review 3.  A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance.

Authors:  E Nagy; L E Maquat
Journal:  Trends Biochem Sci       Date:  1998-06       Impact factor: 13.807

4.  Purification of a novel flavoprotein involved in the thyroid NADPH oxidase. Cloning of the porcine and human cdnas.

Authors:  C Dupuy; R Ohayon; A Valent; M S Noël-Hudson; D Dème; A Virion
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

5.  Thyroid scintigraphy and perchlorate test after recombinant human TSH: a new tool for the differential diagnosis of congenital hypothyroidism during infancy.

Authors:  Laura Fugazzola; Luca Persani; Guia Vannucchi; Marco Carletto; Deborah Mannavola; Maria Cristina Vigone; Francesca Cortinovis; Luciano Beccaria; Virgilio Longari; Giovanna Weber; Paolo Beck-Peccoz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-02-22       Impact factor: 9.236

Review 6.  Primary congenital hypothyroidism: defects in iodine pathways.

Authors:  Jan J M de Vijlder
Journal:  Eur J Endocrinol       Date:  2003-10       Impact factor: 6.664

7.  The H2O2-generating system modulates protein iodination and the activity of the pentose phosphate pathway in dog thyroid.

Authors:  B Corvilain; J van Sande; E Laurent; J E Dumont
Journal:  Endocrinology       Date:  1991-02       Impact factor: 4.736

8.  Monoallelic expression of mutant thyroid peroxidase allele causing total iodide organification defect.

Authors:  L Fugazzola; N Cerutti; D Mannavola; G Vannucchi; C Fallini; L Persani; P Beck-Peccoz
Journal:  J Clin Endocrinol Metab       Date:  2003-07       Impact factor: 5.958

9.  Identification of five novel inactivating mutations in the human thyroid peroxidase gene by denaturing gradient gel electrophoresis.

Authors:  H Bikker; T Vulsma; F Baas; J J de Vijlder
Journal:  Hum Mutat       Date:  1995       Impact factor: 4.878

10.  Inactivating mutations in the gene for thyroid oxidase 2 (THOX2) and congenital hypothyroidism.

Authors:  José C Moreno; Hennie Bikker; Marlies J E Kempers; A S Paul van Trotsenburg; Frank Baas; Jan J M de Vijlder; Thomas Vulsma; C Ris-Stalpers
Journal:  N Engl J Med       Date:  2002-07-11       Impact factor: 91.245

View more
  55 in total

1.  Mice deficient in dual oxidase maturation factors are severely hypothyroid.

Authors:  Helmut Grasberger; Xavier De Deken; Olga Barca Mayo; Houssam Raad; Mia Weiss; Xiao-Hui Liao; Samuel Refetoff
Journal:  Mol Endocrinol       Date:  2012-02-02

2.  Clinical, biochemical, and molecular findings in Argentinean patients with goitrous congenital hypothyroidism.

Authors:  Ana Chiesa; Carina M Rivolta; Héctor M Targovnik; Laura Gruñeiro-Papendieck
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

3.  Heterodimerization controls localization of Duox-DuoxA NADPH oxidases in airway cells.

Authors:  Sylvia Luxen; Deborah Noack; Monika Frausto; Suzel Davanture; Bruce E Torbett; Ulla G Knaus
Journal:  J Cell Sci       Date:  2009-04-15       Impact factor: 5.285

4.  Hypothyroidism-associated missense mutation impairs NADPH oxidase activity and intracellular trafficking of Duox2.

Authors:  Ágnes Donkó; Stanislas Morand; Agnieszka Korzeniowska; Howard E Boudreau; Melinda Zana; László Hunyady; Miklós Geiszt; Thomas L Leto
Journal:  Free Radic Biol Med       Date:  2014-05-20       Impact factor: 7.376

Review 5.  Transient hypothyroidism in the newborn: to treat or not to treat.

Authors:  Neelakanta Kanike; Ajuah Davis; Prem S Shekhawat
Journal:  Transl Pediatr       Date:  2017-10

6.  Duox maturation factors form cell surface complexes with Duox affecting the specificity of reactive oxygen species generation.

Authors:  Stanislas Morand; Takehiko Ueyama; Satoshi Tsujibe; Naoaki Saito; Agnieszka Korzeniowska; Thomas L Leto
Journal:  FASEB J       Date:  2008-12-12       Impact factor: 5.191

7.  When an Intramolecular Disulfide Bridge Governs the Interaction of DUOX2 with Its Partner DUOXA2.

Authors:  Aurore Carré; Ruy A N Louzada; Rodrigo S Fortunato; Rabii Ameziane-El-Hassani; Stanislas Morand; Vasily Ogryzko; Denise Pires de Carvalho; Helmut Grasberger; Thomas L Leto; Corinne Dupuy
Journal:  Antioxid Redox Signal       Date:  2015-04-20       Impact factor: 8.401

8.  Activation of dual oxidases Duox1 and Duox2: differential regulation mediated by camp-dependent protein kinase and protein kinase C-dependent phosphorylation.

Authors:  Sabrina Rigutto; Candice Hoste; Helmut Grasberger; Milutin Milenkovic; David Communi; Jacques E Dumont; Bernard Corvilain; Françoise Miot; Xavier De Deken
Journal:  J Biol Chem       Date:  2009-01-14       Impact factor: 5.157

9.  A clinically euthyroid child with a large goiter due to a thyroglobulin gene defect: clinical features and genetic studies.

Authors:  Pia Hermanns; Samuel Refetoff; Chutintorn Sriphrapradang; Joachim Pohlenz; Jessica Okamato; Leeyat Slyper; Arnold H Slyper
Journal:  J Pediatr Endocrinol Metab       Date:  2013       Impact factor: 1.634

10.  Congenital hypothyroidism caused by a novel homozygous mutation in the thyroglobulin gene.

Authors:  Patrizia Agretti; Giuseppina De Marco; Caterina Di Cosmo; Eleonora Ferrarini; Lucia Montanelli; Brunella Bagattini; Paolo Vitti; Massimo Tonacchera
Journal:  Eur J Pediatr       Date:  2013-03-03       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.